摘要
Abstract
Objective: To explore the expression and significance of the multidrug resistance-related proteins P-glycoprotein (P-gp), multidrug resistance-related protein (MRP), lung resistance protein (LRP) in human non-small cell lung cancer (NSCLC) tissues and paratumor tissues. Methods: Immunohistochemistry (IHC) was used to examine the expression level of proteins P-gp, MRP and LRP in 43 samples of NSCLC and 15 samples of paratumor tissues. Results: The expression rates of P-gp, MRP and LRP in 43 tumor tissues were 74.42% (32/43), 67.44% (29/43) and 88.37% (38/43), respectively, while in 15 paratumor tissues were 13.33% (2/15), 20.00% (3/15) and 6.67% (1/15), respectively. There was significant difference in the expression of proteins (P-gp, MRP and LRP) between lung cancer tissues and paratumor tissues (P ＜ 0.05). The expression of proteins P-gp, LRP in lung adenocarcinoma were higher than that in other pathological carcinomas (P ＜ 0.05). The expression of protein MRP was not related to pathological type, clinical stage and classification of histodifferentiation (P ＞0.05). Conclusion: Multidrug resistance is more common in NSCLC. The proteins of P-gp, MRP and LRP participated in the formation of multidrug resistance in lung cancer. Detection of multidrug resistance-related proteins in lung cancer tissues may be useful to choice drugs.关键词
non-small cell lung cancer (NSCLC)/ chemotherapy/ multidrug resistance (MDR)/ P-gp/ MRP/ LRPKey words
non-small cell lung cancer (NSCLC)/ chemotherapy/ multidrug resistance (MDR)/ P-gp/ MRP/ LRP分类
医药卫生
